JP2022507533A5 - - Google Patents
Info
- Publication number
- JP2022507533A5 JP2022507533A5 JP2021526561A JP2021526561A JP2022507533A5 JP 2022507533 A5 JP2022507533 A5 JP 2022507533A5 JP 2021526561 A JP2021526561 A JP 2021526561A JP 2021526561 A JP2021526561 A JP 2021526561A JP 2022507533 A5 JP2022507533 A5 JP 2022507533A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- diazaspiro
- trifluoroethoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023217954A JP2024019691A (ja) | 2018-11-16 | 2023-12-25 | 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862768575P | 2018-11-16 | 2018-11-16 | |
| US62/768,575 | 2018-11-16 | ||
| PCT/IB2019/001224 WO2020099926A1 (en) | 2018-11-16 | 2019-11-15 | A method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023217954A Division JP2024019691A (ja) | 2018-11-16 | 2023-12-25 | 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022507533A JP2022507533A (ja) | 2022-01-18 |
| JP2022507533A5 true JP2022507533A5 (OSRAM) | 2022-10-05 |
Family
ID=69182543
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021526561A Pending JP2022507533A (ja) | 2018-11-16 | 2019-11-15 | 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法 |
| JP2023217954A Pending JP2024019691A (ja) | 2018-11-16 | 2023-12-25 | 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023217954A Pending JP2024019691A (ja) | 2018-11-16 | 2023-12-25 | 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11413287B2 (OSRAM) |
| EP (1) | EP3880203A1 (OSRAM) |
| JP (2) | JP2022507533A (OSRAM) |
| KR (1) | KR20210105343A (OSRAM) |
| CN (1) | CN113242736A (OSRAM) |
| AU (1) | AU2019382168A1 (OSRAM) |
| CA (1) | CA3119909A1 (OSRAM) |
| WO (1) | WO2020099926A1 (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210105343A (ko) | 2018-11-16 | 2021-08-26 | 알타반트 사이언시스 게엠베하 | 폐동맥 고혈압 및 관련 폐동맥 고혈압의 치료 방법 |
| US20200188399A1 (en) * | 2018-12-17 | 2020-06-18 | Altavant Sciences Gmbh | Method for treating interstitial lung disease |
| WO2020157577A1 (en) * | 2019-01-30 | 2020-08-06 | Altavant Sciences Gmbh | A dosage regime and method for treating pulmonary arterial hypertension with rodatristat ethyl |
| JP2022525202A (ja) * | 2019-03-15 | 2022-05-11 | アルタバント・サイエンシズ・ゲーエムベーハー | 肺動脈性肺高血圧症および各種疾患に伴う肺動脈性肺高血圧症の治療法と１日あたりの投薬量 |
| WO2023062595A1 (en) | 2021-10-14 | 2023-04-20 | Altavant Sciences Gmbh | Treatment of subjects having pulmonary arterial hypertension with rodatristat ethyl |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100046189A (ko) | 2007-07-11 | 2010-05-06 | 렉시컨 파마슈티컬스 인코퍼레이티드 | 폐고혈압 및 관련 질환 및 장애의 치료를 위한 방법 및 조성물 |
| TW201245183A (en) * | 2010-11-05 | 2012-11-16 | Lexicon Pharmaceuticals Inc | Solid forms of (S)-2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoic acid |
| UA119247C2 (uk) * | 2013-09-06 | 2019-05-27 | РОЙВЕНТ САЙЕНСИЗ ҐмбГ | Спіроциклічні сполуки як інгібітори триптофангідроксилази |
| US9399741B2 (en) | 2013-10-09 | 2016-07-26 | Uop Llc | Methods and apparatuses for desulfurizing hydrocarbon streams |
| KR20210102887A (ko) * | 2018-11-14 | 2021-08-20 | 알타반트 사이언시스 게엠베하 | 말초 세로토닌과 관련된 질병 또는 장애를 치료하기 위한 트립토판 하이드록실라제 1 (tph1)의 결정질 스피로사이클릭 화합물 억제제 |
| KR20210105343A (ko) | 2018-11-16 | 2021-08-26 | 알타반트 사이언시스 게엠베하 | 폐동맥 고혈압 및 관련 폐동맥 고혈압의 치료 방법 |
| US20200188399A1 (en) * | 2018-12-17 | 2020-06-18 | Altavant Sciences Gmbh | Method for treating interstitial lung disease |
| US20200188398A1 (en) * | 2018-12-17 | 2020-06-18 | Altavant Sciences Gmbh | Method for treating sarcoidosis-associated pulmonary hypertension |
| WO2020157577A1 (en) | 2019-01-30 | 2020-08-06 | Altavant Sciences Gmbh | A dosage regime and method for treating pulmonary arterial hypertension with rodatristat ethyl |
| JP2022525202A (ja) | 2019-03-15 | 2022-05-11 | アルタバント・サイエンシズ・ゲーエムベーハー | 肺動脈性肺高血圧症および各種疾患に伴う肺動脈性肺高血圧症の治療法と１日あたりの投薬量 |
| CN115379825A (zh) | 2020-01-31 | 2022-11-22 | 阿尔塔万特科学公司 | 用rodatristat治疗肺动脉高压的剂量和方法 |
| US11937070B2 (en) | 2021-07-01 | 2024-03-19 | Tencent America LLC | Layered description of space of interest |
| WO2023079486A1 (en) | 2021-11-03 | 2023-05-11 | Altavant Sciences Gmbh | Treatment of pulmonary arterial hypertension with rodatristat and ambrisentan |
-
2019
- 2019-11-15 KR KR1020217016464A patent/KR20210105343A/ko not_active Ceased
- 2019-11-15 US US16/685,165 patent/US11413287B2/en active Active
- 2019-11-15 WO PCT/IB2019/001224 patent/WO2020099926A1/en not_active Ceased
- 2019-11-15 AU AU2019382168A patent/AU2019382168A1/en not_active Abandoned
- 2019-11-15 CA CA3119909A patent/CA3119909A1/en active Pending
- 2019-11-15 EP EP19839404.1A patent/EP3880203A1/en not_active Withdrawn
- 2019-11-15 JP JP2021526561A patent/JP2022507533A/ja active Pending
- 2019-11-15 CN CN201980083698.9A patent/CN113242736A/zh not_active Withdrawn
-
2022
- 2022-07-18 US US17/813,173 patent/US11911382B2/en active Active
-
2023
- 2023-12-25 JP JP2023217954A patent/JP2024019691A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022525202A5 (OSRAM) | ||
| CA2812034C (en) | Methods for concomitant treatment of theophylline and febuxostat | |
| CN103732062A (zh) | 治疗多发性硬化以及保持和/或增加髓磷脂含量的方法 | |
| JP2025065389A (ja) | 化合物の製剤およびそれらの使用 | |
| JP2015512406A5 (OSRAM) | ||
| KR20160084464A (ko) | 인플루엔자 바이러스 복제 억제제 | |
| WO2010113840A1 (ja) | ソリフェナシン非晶質体を含有した固形医薬組成物 | |
| JP7383124B2 (ja) | リモノイド化合物およびｄｐｐ－４阻害剤を含有する組合せ製品 | |
| US20190233470A1 (en) | Chiral specific boron-containing compounds and their use in treating cancer or amyloidosis | |
| WO2010107610A1 (en) | Method for treatment of diabetes and related conditions with combination therapy and compositions containing such compounds | |
| US20160175286A1 (en) | Selective at2 receptor agonists for use in treatment of cachexia | |
| JP2024019691A (ja) | 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法 | |
| AU2008259864C1 (en) | Methods and compositions for administration of Oxybutynin | |
| CN113784717A (zh) | 一种治疗肺动脉高压和相关性肺动脉高压的方法以及每日给药 | |
| JP2009541455A5 (OSRAM) | ||
| FI3713576T3 (fi) | Yhdiste kaavan (i) mukaan ja ponatinibi käytettäväksi bcr-abl-mutaatioiden kanssa esiintyvän kroonisen myelooisen leukemian hoidossa | |
| US20030050329A1 (en) | Synergistic combination comprising roflumilast and a PDE-3 inhibitor | |
| JPWO2014129513A1 (ja) | 潰瘍性大腸炎の予防または治療剤と新規フラーレン誘導体 | |
| CN100372533C (zh) | 腹泻为主大肠激惹综合征的治疗制剂 | |
| JP2022518288A5 (OSRAM) | ||
| JP5376785B2 (ja) | 医薬組成物 | |
| JP2010536827A (ja) | ある種の炎症性障害の治療に有用なカルボニルアミノ誘導体 | |
| JP2018035165A (ja) | Ｓ−（＋）−フルルビプロフェンを含む原薬の調製物、医薬組成物、そして剤形 | |
| CH629667A5 (fr) | Composition pharmaceutique agissant sur la motricite gastro-intestinale. | |
| JP6714225B2 (ja) | 肝細胞癌の予防又は治療のための医薬 |